Study of the Safety and Effectiveness of JUVÉDERM VOLUX™ XC Injectable Gel for Restoring Jawline Definition
- Conditions
- Jawline Definition
- Registration Number
- NCT03712137
- Lead Sponsor
- Allergan
- Brief Summary
This study will evaluate the safety and effectiveness of JUVÉDERM VOLUX™ XC injectable gel for restoring jawline definition
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 206
- Has "Moderate" or "Severe" loss of jawline definition as determined by the EI using the ALJDs (Grade 2 or 3 on the ALJDS) on both sides. The grade does not have to be the same on both sides, but must be Grade 2 or 3
- Treating Investigator (TI) considers the subject's jaw amenable to an improvement of at least 1 grade on the scale for the jawline definition
- Written Informed Consent (IC) has been obtained
- Has ever received permanent facial implants (eg, polymethylmethacrylate, silicone, polytetrafluoroethylene) anywhere in the face or neck, or is planning to be implanted with any of these products during the study
- Has ever undergone fat injections in the malar, chin or jawline area or is planning to undergo this procedure during the study
- Has undergone semipermanent dermal filler treatment (eg, calcium hydroxyapatite, poly-L-lactic acid) below the subnasale within 36 months before enrollment or is planning to undergo such treatment during the study
- Has received deoxycholic acid treatment in the submental region in the last 6 months
- Has active autoimmune disease
- Females who are pregnant, nursing, or planning a pregnancy during the course of the study
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Percentage of Participants Who Show ≥ 1-point Jawline Improvement on Both Sides From Baseline on the Allergan Loss of Jawline Definition Scale (ALJDS) Month 6 The ALJDS is an Investigator assessment of loss of jawline definition measured by a 5-point scale (0=None, 1=Mild, 2=Moderate, 3=Severe, 4=Extreme)
- Secondary Outcome Measures
Name Time Method Percentage of Participants Who Note "Improved" or "Much Improved" in Jawline Area as Assessed by the Evaluating Investigator Using the Global Aesthetic Improvement Scale (GAIS) Month 6 The Evaluating Investigator (EI) will assess the aesthetic improvement of the jawline area using the GAIS 5-point scale where: 2=much improved, 1=improved, 0=no change, -1=worse and -2=much worse. The percentage of participants who the Evaluating Investigator assesses as 2=much improved or 1=improved will be reported.
Percentage of Participants Who Note "Improved" or "Much Improved" in Jawline Area as Assessed by the Participant Using the Global Aesthetic Improvement Scale (GAIS) Month 6 The participant will assess the aesthetic improvement of the jawline area using the GAIS 5-point scale where: 2=much improved, 1=improved, 0=no change, -1=worse and -2=much worse. The percentage of participants who assess themselves as 2=much improved or 1=improved will be reported.
Change From Baseline in Overall Score for FACE-Q™ Satisfaction With Lower Face and Jawline Score Baseline to Month 6 The subject will assess satisfaction using the 5 questions on the Satisfaction of Lower Face and Jawline scale of the FACE-Q™ questionnaire measured on a 4-point scale (1=Very Dissatisfied 2=Somewhat Dissatisfied, 3=Somewhat Satisfied, 4=Very Satisfied). The raw scale summed score will then be converted into a Rasch-transformed score from 0 (worst) to 100 (best)
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (19)
Total Skin and Beauty Dermatology Center, PC
🇺🇸Birmingham, Alabama, United States
Westside Aesthetics
🇺🇸Los Angeles, California, United States
Artemedica
🇺🇸Santa Rosa, California, United States
Center for Dermatology and Dermatologic Surgery
🇺🇸Washington, District of Columbia, United States
Susan H Weinkle, MD
🇺🇸Bradenton, Florida, United States
Hevia Cosmetic Dermatology
🇺🇸Coral Gables, Florida, United States
Skin Research Institute LLC
🇺🇸Coral Gables, Florida, United States
Baumann Cosmetic and Research Institute
🇺🇸Miami, Florida, United States
DeNova Research dba Arano, LLC
🇺🇸Chicago, Illinois, United States
Callender Center for Clinical Research
🇺🇸Glenn Dale, Maryland, United States
Scroll for more (9 remaining)Total Skin and Beauty Dermatology Center, PC🇺🇸Birmingham, Alabama, United States